The regulatory boundary between "wellness" and "medical device" was fundamentally redefined in January 2026. This panel explores the strategic shift toward Connected Health, examining how recent FDA "Red Tape" cuts and expanded enforcement discretion are accelerating the commercialization of digital health ecosystems, AI-enabled sensors, and remote monitoring platforms.
The regulatory landscape for connected medical technology reached a critical pivot point in January 2026. As healthcare shifts from a reactive model toward proactive, preventive care, the "Red Tape" governing digital health has been significantly rewritten. These reforms have expanded enforcement discretion for a wide array of connected technologies—from high-fidelity clinical sensors to AI-driven decision support—allowing for faster innovation and market entry.
This session brings together a panel of industry leaders to dissect the practicalities of scaling Connected Health & Digital ecosystems. We will move beyond hardware specifics to discuss the regulatory architecture required to navigate this new era.
Key Discussion Pillars:
By attending this event, participants will be able to:
| Time | Description |
| 5:00 PM – 5:30 PM | Registration & Networking |
| 5:30 PM – 5:45 PM | RAPS SF Chapter Welcome & Introduction |
| 5:45 PM – 6:00 PM | Triple Ring Technologies Introduction |
| 6:00 PM – 7:00 PM | Panel Discussion: Scaling Connected Health in the 2026 Regulatory Landscape |
| 7:00 PM – 8:00 PM | Triple Ring Technology Facility Tour and Networking |
Triple Ring Technologies (TRT)
39655 Eureka Drive
Newark, CA 94560
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted in writing to [email protected]. Cancellations will receive a full refund minus a 20% administrative fee. RAPS is unable to accept cancellations by phone.
Paid registration substitutions may be accepted with written approval from RAPS for requests received before the start of the event. To transfer a registration, email [email protected] with the event title, name of the original registrant and the contact information for the new attendee.
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].






Principal, Novarum MDRQ Consulting
Ritam Priya is a Regulatory Affairs leader specializing in digital health, SaMD, and AI/ML-enabled medical devices, known for bridging innovation and regulatory strategy to enable global product success.
Medical Technology Fellow, Triple Ring
Walt Cecka has over 35 years of experience in translational medicine design and development of first-to-market complex medical devices and combination products. Walt has held senior leadership product development positions at Nektar Therapeutics (inhaled insulin and anti-infective delivery systems), Bio-Molecular Technologies (protein processing instrumentation), Baxter (LVAD technology), Cholestech (POC lipid panels), and Nellcor (In-line capnography and fetal oximeters).
As a medical technology fellow with over 15 years at Triple Ring, Walt primarily collaborates with our entrepreneurial clients to evolve their novel ideas into concept and product development programs that offer significant patient care benefits across a broad range of clinical applications and technologies.
Walt has co-authored several peer-reviewed posters, has articles published in trade association magazines and newsletters, and has international patents in respiratory care and pulmonary drug delivery. He is a serial mentor with engagements at accelerators including California Life Sciences and MedTech Innovators, and guest lectures for the UCSF/UC Berkeley Masters in Translational Medicine program (MTM). Walt holds a BSME from California Polytechnic State University, San Luis Obispo.

SVP of RA and QA, BioIntelliSense Inc.
Yusi Liu has a background in Industrial Design and nearly 20 years of experience in medical device design, development, regulatory affairs, and quality systems. His career spans medical device startups, large enterprises, and RA/QA consulting, with a focus on emerging technologies including wearables, digital health, software-driven devices, and ML/AI-enabled medical technologies.
Yusi specializes in enabling rapid product innovation while maintaining regulatory compliance, helping organizations navigate complex regulatory pathways while sustaining agile product development.
Since 2019, Yusi has served as Head of Regulatory and Quality at BioIntelliSense Inc., a leading wearable medical device and data services company focused on physiological monitoring and remote patient monitoring (RPM) solutions.
:
liuyusi

Principal Regulatory Affairs Specialist , MiniMed
Jeanne Zhang is a Principal Regulatory Affairs Specialist at MiniMed, where she leads global regulatory strategy for next-generation software-driven medical devices, including mobile applications and interoperable diabetes management platforms. She brings over a decade of experience spanning global medical device regulatory affairs, auditing and quality systems, including SaMD and Class III products.
:
jeannez

Highly motivated and passionate RAC certified Regulatory Affairs professional with a decade of experience supporting the full life cycle of innovative medical/health technologies.
We recently upgraded our website. Help us make sure it serves you and your peers!
The team at RAPS is interested in your feedback on design, navigation, content, performance, and anything else you want us to know.
Take Our Survey